Predictive Oncology updates ATM offering cap to $3.4M under prospectus supplement

Axe Compute Inc.

Filed prospectus supplement limiting ATM sales to $3,398,000 aggregate under General Instruction I.B.6.
Already sold $684,467 in shares under the ATM program as of June 2, 2025.
Cap may increase if public float rises; currently subject to one-third of public float limit.
No other material events reported; filing includes legal opinion from DLA Piper.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.